7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-10-06NCT06023589
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsIrritability Associated With Autism Spectrum DisorderRecruitingPhase 32026-09-25NCT06706674
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderBipolar and Related Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, autism spectrum disorder, bipolar disorder, mood disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-25NCT06229210
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant HypertensionDifficult to Control HypertensionRecruitingPhase 22026-09-23NCT06343298
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.bipolar I disorder, depressive disorderRecruitingPhase 32026-07-27NCT04777357
Non-Invasive ICP Monitoring StudyIntracranial PressureRecruitingNot stated2026-04-22NCT07113353
OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Experiencing Substance MisuseChemically-Induced Disorders, psychiatric disorder, substance-related disorderRecruitingNot applicable2025-09-08NCT07159633